PE anti-mouse CD31 (PECAM-1) Antibody and 2 more items

The University of Nebraska Medical Center, a state agency located in Nebraska, awarded a purchase order (PO #4800178410) to BioLegend Inc., a vendor based in Pasadena, California, on February 11, 2026. The contract, valued at $767, encompasses the procurement of three research-grade antibody products for delivery to UNMC Shipping and Receiving in Omaha, Nebraska by February 17, 2026. The line items include PE anti-mouse CD31 (Platelet Endothelial Cell Adhesion Molecule-1) Antibody ($231), PE anti-mouse CD144 (VE-cadherin) Antibody ($360), and Alexa Fluor 647 Rat IgG2b Isotype Control ($176), each ordered in single unit quantities.

Performance of this purchase order was completed within a six-day period, with delivery scheduled for February 17, 2026 under freight prepaid, F.O.B. Destination terms. The purchase order is governed by the Standard Terms of Purchase of the University of Nebraska Board of Regents, with payment terms established at Net 30 days. BioLegend Inc. was required to acknowledge acceptance of the purchase order within ten days of issuance. The transaction benefits from UNMC's tax-exempt status (Federal Tax Identification #05-8905401).